Page last updated: 2024-08-25

2,2,2-trifluoroethanesulfonyl chloride and Adenocarcinoma

2,2,2-trifluoroethanesulfonyl chloride has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Begent, RH; Boden, JA; Boden, R; Chester, KA; Delgado, C; Fisher, D; Francis, GE; Herraez, A; Keep, PA; Pedley, RB1

Other Studies

1 other study(ies) available for 2,2,2-trifluoroethanesulfonyl chloride and Adenocarcinoma

ArticleYear
Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification.
    British journal of cancer, 1996, Volume: 73, Issue:2

    Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Binding Sites, Antibody; Biological Availability; Carcinoembryonic Antigen; Colonic Neoplasms; Female; Humans; Immunoglobulin Fab Fragments; Linear Models; Mice; Mice, Nude; Neoplasm Transplantation; Polyethylene Glycols; Recombinant Fusion Proteins; Sulfones; Tissue Distribution

1996